<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Assessing Adhesion With Transdermal and Topical Delivery Systems for Abbreviated New Drug Applications; Revised Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Assessing Adhesion With Transdermal and Topical Delivery Systems for Abbreviated New Drug Applications; Revised Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2023-04-13 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a revised draft guidance for industry entitled "Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs" (Revision 2). This draft guidance (Revision 2) revises the Revision 1 draft guidance of the same name, which was announced in the Federal Register on October 10, 2018. This revised draft guidance provides recommendations for the design and conduct of studies evaluating the adhesion performanc...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-07770</p>
    <p><strong>Publication Date:</strong> 2023-04-13</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/04/13/2023-07770/assessing-adhesion-with-transdermal-and-topical-delivery-systems-for-abbreviated-new-drug">https://www.federalregister.gov/documents/2023/04/13/2023-07770/assessing-adhesion-with-transdermal-and-topical-delivery-systems-for-abbreviated-new-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-07770</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
